Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 35 clinical trials
Effects of Internet-based ERITA Added to TAU in Young People With Non-Suicidal Self-Injury (TEENS) Feasibility Trial

We aim to assess the feasibility of methods, procedures, and safety of internet-based Emotion Regulation Individual Therapy for Adolescents (ERITA) as add on to treatment as usual (TAU) in 13-17-year-old patients with non-suicidal self-injury referred to psychiatric services.

  • 0 views
  • 19 Feb, 2024
CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

Adding bortezomid in the relapsed chemotherapy protocol may increase the toxicity and even treatment related mortality. In this protocol, we suggested to add during the Consolidation after the induction therapy.

remission
rituximab
cns involvement
hematopoietic stem cell transplantation
leukemic cells
  • 0 views
  • 19 Feb, 2024
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome

irritable bowel syndrome
mebeverine
stomach pain
abdominal pain
  • 0 views
  • 19 Feb, 2024
Randomised Evaluation of COVID-19 Therapy

RECOVERY is a randomised trial investigating whether treatment with either Lopinavir-Ritonavir, Hydroxychloroquine, Corticosteroids, Azithromycin, Convalescent plasma or Tocilizumab prevents death in patients with COVID-19.

ritonavir
aspirin
hydroxychloroquine
immunoglobulin
immunoglobulins
  • 0 views
  • 19 Feb, 2024
Treating Sleep in Teens With ADHD

Sleep problems are common in adolescence and recognized as an international public health concern given their links to a range of adverse outcomes. Adolescents with attention-deficit/hyperactivity disorder (ADHD) experience more sleep problems than their peers, including delayed sleep onset, shorter sleep duration, poorer sleep quality, more sleep variability, and greater …

attention deficit disorder
sleepiness
adhd
mental illness
psychiatric disorder
  • 0 views
  • 19 Feb, 2024
Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children

MIMOSA study aims to characterize from behavioral, neurophysiological and neurocognitive perspectives children and adolescents with attention deficit hyperactivity disorder (ADHD), in order to identify a possible biomarker of response to medication treatments. To achieve this aim, in the study children with ADHD (drug naive) are recruited and undergo behavioral and …

attention deficit hyperactivity disorder
psychiatric disorders
methylphenidate
attention deficit disorder
psychiatric disorder
  • 0 views
  • 19 Feb, 2024
Effectiveness of a Mobile Neurofeedback for ADHD Youth

Objective: Verification of ADHD Treatment Effectiveness of Mobile Neurofeedback to Subjects of Child and Youth with ADHD. Method: Mobile Neurofeedback Program is implemented for 165 ADHD patients aged 8 to 15 to verify their effectiveness by conducting pre-post evaluation.

magnetic resonance imaging of brain
sham treatment
attention deficit hyperactivity disorder
neuropsychological test
neurofeedback
  • 0 views
  • 19 Feb, 2024
Short Structured Psychological Intervention for Adults With ADHD - a Randomized Controlled Trial

The main objective is to evaluate whether SAINT will show better outcomes on measures of ADHD-related symptoms, everyday function, and quality-of-life measures, when compared to the self-help material, and if any possible differences in outcomes are related to better treatment adherence in SAINT.

attention deficit hyperactivity disorder
psychiatric symptoms
cns stimulants
substance use
stimulant
  • 0 views
  • 19 Feb, 2024
Nigella Sativa in COVID-19

If encouraging outcomes occurred, NS supplementation may be recommended as an add-on to standard care protocol to enhance the recovery from COVID-19 disease in the current emerging situation.

covid-19
pneumonia
SARS
respiratory infection
upper respiratory infection
  • 0 views
  • 19 Feb, 2024
Doxapram Therapy in Preterm Infants (DOXA Trial)

Doxapram is a respiratory stimulant that has been administered off-label to treat AOP. Doxapram, as add-on treatment, seems to be effective in treating AOP and to prevent invasive mechanical ventilation. It is unclear if a preterm infant benefit from doxapram treatment on the longer term.

nervous
mechanical ventilation
apnea
off-label
doxapram
  • 0 views
  • 19 Feb, 2024